Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002050492-25-000001·Actyus Private Equity SGIIC, S.A.
Schedule 13G ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2025-03-31
- Filing-level shares
- 856,382.00
- Percent of class
- 5.4%
- Actyus Private Equity SGIIC, S.A.
Shares: 856,382.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050492-25-000001
- Form type
- SCHEDULE 13G/A
- Filer
- Actyus Private Equity SGIIC, S.A.
- CIK
- CIK 2050492
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership